Manipal Health Enterprises Stock: price and insider trades · India
IN·Mcap ₹845B
Manipal Health Enterprises: what insiders have been doing
Only a handful of insider records exist for Manipal Health Enterprises, the last one from 25 August 2026, too few to describe a trend. Source: insider filings from SEBI (PIT + SAST). Past trades are no guide to future returns.
Insider Decl.
1
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
Analyst consensus: bullish or bearish?
Analysts rate Manipal Health Enterprises Buy (bullish), based on 9 analysts. Average price target: ₹825.56.
Fundamental score
Ranked 17,492 of 26,911 companies
41.8
score / 100
Value29
Quality54
FCF yld0.9%
Earn yld0.8%
EV/EBITDA34.6x
ROE·
Gross mgn65%
Net mgn6.0%
Debt/EBITDA4.5x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended March 2026 · cache
₹642.40
Analyst consensus
9 analystsBuy
₹750.00Target ₹825.56(+29%)₹880.00
Income statement
Revenue₹109.4B
Gross profit₹71B65% margin
EBITDA₹28.3B26% margin
Net income₹6.5B7.8% margin
Valuation
PER (trailing)131.1x
PER (forward)45.0x
P/Book9.0x
Balance sheet & cash
Market cap₹845B
Total debt₹128.6B
Free Cash Flow₹7.6B
Debt / Equity146%
Profitability & ownership
% insiders86.1%
% institutions6.4%
Last declaration on 25 August 2026
Declarations1 total
- 232,147,755 shares-CreationSEBI:5cd653fccab024de0048d41ee3af0b782ac8a050
1 of 1 declaration
About Manipal Health Enterprises
Manipal Health Enterprises is an Indian company specializing in healthcare services, providing medical care through a network of hospitals and clinics. It is listed on the Bombay Stock Exchange.